Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders.
Ontology highlight
ABSTRACT: Development of tools for direct thrombus imaging represents a key step for diagnosis and treatment of stroke. Nanoliposomal carriers of contrast agents and thrombolytics can be functionalized to target blood thrombi by small protein binders with selectivity for fibrin domains uniquely formed on insoluble fibrin. We employed a highly complex combinatorial library derived from scaffold of 46 amino acid albumin-binding domain (ABD) of streptococcal protein G, and ribosome display, to identify variants recognizing fibrin cloth in human thrombus. We constructed a recombinant target as a stretch of three identical fibrin fragments of 16 amino acid peptide of the Bβ chain fused to TolA protein. Ribosome display selection followed by large-scale Enzyme-Linked ImmunoSorbent Assay (ELISA) screening
SUBMITTER: Petrokova H
PROVIDER: S-EPMC6955937 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA